224 related articles for article (PubMed ID: 11117873)
21. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
22. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P
Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991
[TBL] [Abstract][Full Text] [Related]
23. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.
Haley EC; Kassell NF; Apperson-Hansen C; Maile MH; Alves WM
J Neurosurg; 1997 Mar; 86(3):467-74. PubMed ID: 9046304
[TBL] [Abstract][Full Text] [Related]
24. HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage.
Gathier CS; van den Bergh WM; Slooter AJ;
Int J Stroke; 2014 Apr; 9(3):375-80. PubMed ID: 23692645
[TBL] [Abstract][Full Text] [Related]
25. Clazosentan, an endothelin receptor antagonist, prevents early hypoperfusion during the acute phase of massive experimental subarachnoid hemorrhage: a laser Doppler flowmetry study in rats.
Schubert GA; Schilling L; Thomé C
J Neurosurg; 2008 Dec; 109(6):1134-40. PubMed ID: 19035733
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.
Westermaier T; Stetter C; Vince GH; Pham M; Tejon JP; Eriskat J; Kunze E; Matthies C; Ernestus RI; Solymosi L; Roosen K
Crit Care Med; 2010 May; 38(5):1284-90. PubMed ID: 20228677
[TBL] [Abstract][Full Text] [Related]
27. Thick and Diffuse Subarachnoid Blood as a Treatment Effect Modifier of Clazosentan After Subarachnoid Hemorrhage.
Mayer SA; Aldrich EF; Bruder N; Hmissi A; Macdonald RL; Viarasilpa T; Marr A; Roux S; Higashida RT
Stroke; 2019 Oct; 50(10):2738-2744. PubMed ID: 31394993
[TBL] [Abstract][Full Text] [Related]
28. Plasma endothelin and big endothelin concentrations and serum endothelin-converting enzyme activity following aneurysmal subarachnoid hemorrhage.
Juvela S
J Neurosurg; 2002 Dec; 97(6):1287-93. PubMed ID: 12507125
[TBL] [Abstract][Full Text] [Related]
29. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article.
Tseng MY; Hutchinson PJ; Richards HK; Czosnyka M; Pickard JD; Erber WN; Brown S; Kirkpatrick PJ
J Neurosurg; 2009 Jul; 111(1):171-80. PubMed ID: 19344224
[TBL] [Abstract][Full Text] [Related]
30. Levosimendan, a new therapeutic approach to prevent delayed cerebral vasospasm after subarachnoid hemorrhage?
Konczalla J; Wanderer S; Mrosek J; Gueresir E; Schuss P; Platz J; Seifert V; Vatter H
Acta Neurochir (Wien); 2016 Nov; 158(11):2075-2083. PubMed ID: 27614436
[TBL] [Abstract][Full Text] [Related]
31. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial.
Shibuya M; Suzuki Y; Sugita K; Saito I; Sasaki T; Takakura K; Nagata I; Kikuchi H; Takemae T; Hidaka H
J Neurosurg; 1992 Apr; 76(4):571-7. PubMed ID: 1545249
[TBL] [Abstract][Full Text] [Related]
32. Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage: a comparative study.
Sanchez-Peña P; Nouet A; Clarençon F; Colonne C; Jean B; Le Jean L; Fonfrede M; Aout M; Vicaut E; Puybasset L
Crit Care Med; 2012 Feb; 40(2):594-602. PubMed ID: 21926584
[TBL] [Abstract][Full Text] [Related]
33. Neurokinin-1 receptor antagonism in a rat model of subarachnoid hemorrhage: prevention of upregulation of contractile ETB and 5-HT1B receptors and cerebral blood flow reduction.
Ansar S; Svendgaard NA; Edvinsson L
J Neurosurg; 2007 May; 106(5):881-6. PubMed ID: 17542534
[TBL] [Abstract][Full Text] [Related]
34. Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: results of a multicenter, placebo-controlled double-blind trial.
Asano T; Takakura K; Sano K; Kikuchi H; Nagai H; Saito I; Tamura A; Ochiai C; Sasaki T
J Neurosurg; 1996 May; 84(5):792-803. PubMed ID: 8622153
[TBL] [Abstract][Full Text] [Related]
35. CT perfusion imaging of cerebral microcirculatory changes following subarachnoid hemorrhage in rabbits: Specific role of endothelin-1 receptor antagonist.
Wu Q; Zheng R; Wang J; Wang J; Li S
Brain Res; 2018 Dec; 1701():196-203. PubMed ID: 30244111
[TBL] [Abstract][Full Text] [Related]
36. High-dose simvastatin for aneurysmal subarachnoid hemorrhage: a multicenter, randomized, controlled, double-blind clinical trial protocol.
Wong GK; Liang M; Tan H; Lee MW; Po YC; Chan KY; Poon WS
Neurosurgery; 2013 May; 72(5):840-4. PubMed ID: 23392270
[TBL] [Abstract][Full Text] [Related]
37. Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis.
Sillberg VA; Wells GA; Perry JJ
Stroke; 2008 Sep; 39(9):2622-6. PubMed ID: 18658040
[TBL] [Abstract][Full Text] [Related]
38. Endothelin-1 and endothelin receptor gene variants and their association with negative outcomes following aneurysmal subarachnoid hemorrhage.
Gallek M; Alexander S; Crago E; Sherwood P; Horowitz M; Poloyac S; Conley Y
Biol Res Nurs; 2013 Oct; 15(4):390-7. PubMed ID: 22997346
[TBL] [Abstract][Full Text] [Related]
39. The effects of endothelin antagonist BQ-610 on cerebral vascular wall following experimental subarachnoid hemorrhage and cerebral vasospasm.
Cirak B; Kiymaz N; Ari HH; Ugras S
Clin Auton Res; 2004 Jun; 14(3):197-201. PubMed ID: 15241650
[TBL] [Abstract][Full Text] [Related]
40. Improved survival after aneurysmal subarachnoid hemorrhage: review of case management during a 12-year period.
Cesarini KG; Hårdemark HG; Persson L
J Neurosurg; 1999 Apr; 90(4):664-72. PubMed ID: 10193611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
